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Background: Retinol-binding protein 4 (RBP4) is an adipokine identified as a marker of insulin 
resistance in mice and humans. Protein tyrosine phosphatase 1B (PTP1B) expression levels as 
well as other genes involved in the endoplasmic reticulum (ER) stress response are increased 
in adipose tissue of obese, high-fat-diet-fed mice. In this study we investigated if serum and/
or adipose tissue RBP4 protein levels and expression levels of PTP1B and other ER stress-
response genes are altered in obese and obese/diabetic men resident in northeast Scotland.
Methods: We studied three groups of male volunteers: (1) normal/overweight (body mass 
index [BMI] , 30), (2) obese (BMI . 30), and (3) obese/diabetic (BMI . 30) control-
ling their diabetes either by diet or the antidiabetic drug metformin. We analyzed their 
serum and adipose tissue RBP4 protein levels as well as adipose tissue mRNA expres-
sion of PTP1B, binding immunoglobulin protein (BIP), activated transcription factor 4 
(ATF4), and glucose-regulated protein 94 (GRP94) alongside other markers of adiposity 
(percentage body fat, leptin, cholesterol, triglycerides) and insulin resistance (oral glucose 
tolerance tests, insulin, homeostatic model assessment–insulin resistance, C-reactive protein, 
and adiponectin).
Results: We found that obese Scottish subjects had significantly higher serum RBP4 protein 
levels in comparison to the normal/overweight subjects (P , 0.01). Serum RBP4 levels were 
normalized in obese/diabetic subjects treated with diet or metformin (P , 0.05). Adipose tissue 
RBP4 protein levels were comparable between all three groups of subjects as were serum and 
adipose transthyretin levels. Adipose tissue PTP1B mRNA levels were increased in obese sub-
jects in comparison to normal/overweight subjects (P , 0.05); however diet and/or metformin 
treatment did not reverse this effect. Adipose tissue BIP, ATF4, and GRP94 expression levels 
were unchanged in obese and obese/diabetic subjects.
Conclusions: Human obesity results in an increase in serum but not adipose tissue RBP4 
protein levels, and these are normalized in obese/diabetic subjects, which exhibit improvements 
in insulin sensitivity through diet or metformin treatment. However, while adipose tissue PTP1B 
mRNA levels increase in obese Scottish subjects, these remain high in obese/diabetics on diet 
or metformin treatment.
Keywords: obesity, diabetes, metformin, PTP1B, RBP4, TTR, ER stress, UPR, GRP94, BIP, 
ATF4, insulin resistance, glucose homeostasis
Introduction
Obesity is a major risk factor for a number of metabolic diseases, such as type 2 
diabetes, cardiovascular disease, cancer, Alzheimer’s disease, and others. Recent 
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studies clearly demonstrate that adipose tissue acts as an 
endocrine and paracrine organ by secreting various proteins 
(adipokines).1 These bioactive molecules, including leptin, 
adiponectin, visfatin, omentin, tumor necrosis factor-α, 
resistin, retinol-binding protein 4 (RBP4), and many others, 
influence metabolic processes, such as food intake, glucose 
and lipid metabolism, inflammation, and insulin resistance.2 
Adipose tissue is an important inflammatory source in obesity 
and type 2 diabetes due to the cytokines produced by the 
adipose tissue as well as macrophages that have infiltrated 
the adipose tissue during the progression of obesity.3
RBP4 is an adipokine recently discovered to be elevated 
in insulin-resistant states and obesity in mice4 and humans.3,5 
RBP4 is a transport protein for retinol (vitamin A) and is 
normally bound to transthyretin (TTR) in the circulation. In 
many studies the level of serum RBP4 elevation correlates 
highly with the degree of insulin resistance in both mice and 
humans, and serum RBP4 levels are suggested to be highly 
predictive of metabolic syndrome risk in a large population-
based study.6 However, not all studies agree with these 
results and find that either serum RBP4 levels are unaltered 
in insulin resistance/diabetes or that RBP4 mRNA levels 
in human abdominal subcutaneous tissue levels are even 
downregulated in obesity.7
Protein tyrosine phosphatase 1B (PTP1B) is a ubiqui-
tously expressed nonreceptor tyrosine phosphatase and a key 
negative regulator of leptin and insulin signaling.1 High-fat 
diet feeding in mice has been shown to increase PTP1B 
  levels in a number of tissues, such as the brain, muscle, liver, 
and adipose tissue,1,8–10 and global PTP1B−/− mice exhibit 
reduced adiposity and improvements in insulin sensitivity.11,12 
  However, this improvement in insulin sensitivity is tissue 
specific as adipose-specific PTP1B−/− mice exhibit an increase 
in leptin production and mild glucose intolerance.1 Low-grade 
inflammation, such as that caused by obesity and prolonged 
high-fat diet feeding, has been shown to lead to an induction 
of endoplasmic reticulum (ER) stress13–15 and result in an 
increase in PTP1B protein and mRNA expression levels.10,16 
An increase in ER stress response genes, such as binding 
immunoglobulin protein (BIP), activated transcription factor 
4 (ATF4), and glucose-regulated protein 94 (GRP94) in mice 
is associated with obesity and insulin resistance.
In this study we aimed to investigate if serum and adi-
pose tissue RBP4 protein levels are altered in human obesity 
and type 2 diabetes in a cohort of men resident in northeast 
Scotland and if this can be manipulated by either diet or met-
formin treatment in obese/diabetic subjects. The method of 
measuring RBP4 levels has been suggested to account for some 
of the discrepancies between different studies and quantitative 
western blotting for protein RBP4, and using full-length RBP4 
antibody has been suggested as a “gold standard” for RBP4 
level determination.17 We therefore used this method to assess 
both serum and adipose tissue RBP4 protein levels in normal/
overweight, obese, and obese/diabetic subjects and correlated 
these with other markers of adiposity and insulin resistance. 
In addition, while there is evidence to support that obesity and 
high-fat diet feeding leads to induction of the ER stress response 
and induction of the ER stress-response genes in adipose tissue 
in mice,13 to our knowledge not much data  are available with 
regards to humans. We therefore analyzed PTP1B expression 
levels and levels of BIP, ATF4, and GRP94 in adipose tissue 
of normal/overweight subjects and compared it to obese 
and obese/diabetic subjects in northeast Scotland.
Methods
Volunteers and protocols
Male, nonsmoking subjects were included if they were 
not on any special diet and had a normal medical exami-
nation excluding their diabetic status, where appropriate. 
Only those diabetic volunteers who were controlling their 
diabetes by diet or metformin (500 mg four times per day) 
were accepted. These inclusion criteria were also checked 
with the participant’s primary-care physician. All patients 
provided informed written consent before inclusion in the 
study, which was approved by the North of Scotland Research 
Ethics Committee.
The study comprised three groups (Table 1): normal/
overweight volunteers with BMI , 30 (n = 21), obese vol-
unteers with BMI . 30 (n = 9) and obese/diabetic volunteers 
with BMI . 30 (n = 14) controlling their diabetes by diet 
or metformin. All blood samples were taken overnight after 
10–12 hours fasting. Each subject’s height, weight, waist, 
and hip were measured using standard protocols.18 Percentage 
body fat was determined using air-displacement whole-body 
plethysmography (BodPod Body Composition System; Life 
Measurements Instruments, Concord, CT).
Fat biopsies
A subcutaneous, abdominal region, adipose tissue biopsy was 
taken after an overnight fast (10–12 hours). The biopsy was 
performed in the periumbilical triangle with a 14G needle after 
intradermal anesthesia with 2% lignocaine. Adipose tissue 
was drawn by successive suctions into a 50 mL syringe. We 
routinely obtained 0.5–1 g adipose tissue. Tissue was immedi-
ately frozen in liquid nitrogen, and samples were subsequently 
processed for RNA and protein extraction.
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Oral glucose tolerance testing
Volunteers fasted overnight (10–12 hours) for oral glucose 
tolerance testing (OGTT). Blood samples were drawn at 0 and 
120 minutes after consuming 75 g of glucose. Plasma glucose 
levels (and triacylglycerol) were measured using an automated 
clinical analyzer (Kone Oyj, Espoo, Finland). Plasma insu-
lin was measured using an enzyme-linked immunosorbent 
assay (ELISA) (Mercodia, Uppsala, Sweden). The interassay 
and intraassay coefficients of variation for insulin using this 
assay were 2.6%–3.6% and 2.8%–3.4%,   respectively. Homeo-
static model assessment of insulin resistance (HOMA-IR) 
was calculated using fasting glucose and insulin values. 
Total cholesterol, low-density lipoprotein, and high-density 
lipoprotein cholesterol were analyzed using commercial kits 
(Microgenics GmbH, Milton Keynes, UK).
Plasma ELISAs
Plasma leptin and C-reactive protein (CRP) were detected, in 
duplicate, using commercial kits according to the manufac-
turer’s instructions (R&D Systems, Abingdon, UK). For leptin 
the minimum level of detection was ,7.8 pg/mL and the interas-
say and intraassay CVs were 4.2% and 3.2%, respectively. For 
CRP the minimum level of detection was 0.005 ng/mL and the 
interassay and intraassay CVs were 8.7% and 8.7%, respectively.
Biochemical analyses
Adipose tissue lysates were prepared by extraction in radio 
immunoprecipitation assay (RIPA) buffer, as described 
previously.1,19 Ten micrograms of human adipose tissue lysates 
were used for analysis. Serum RBP4 levels were measured 
by adding 1 µL of patient’s serum directly into 29 µL of 1% 
sodium dodecyl sulfate (SDS)-loading buffer and boiling for 
10 minutes.20 Proteins were resolved by SDS-polyacrylamide gel 
electrophoresis (10% gels in 2-(N-morpholino)ethanesulfonic 
acid buffer), transferred to nitrocellulose membranes and 
immunoblots performed using polyclonal antibodies against 
antihuman RBP4 and TTR, following the manufacturer’s 
instructions. Proteins were visualized using enhanced-
chemiluminescence and quantified using a high-sensitivity 
imaging system (Fusion imaging system and Bio1D software; 
Vilber Lourmat, Marne-La-Vallée, France).1,10,19,21
mRNA expression analysis
Total RNA was isolated from adipose tissue using TRI 
Reagent® (Ambion, Warrington, UK) according to the 
manufacturer’s protocol. First-strand complementary DNA 
was synthesized from 1 µg of total RNA employing the 
Biorscript™ Preamplification System (Bioline, London, 
UK) and an oligo(dT)12–18 primer as the reverse primer. 
Table 1 Baseline characteristics of the normal/overweight, obese, and diabetic study volunteers. Normal/overweight volunteers have 
a BMI , 30
n Normal/overweight Obese Obese/diabetic P value (ANOVA)
21 9 14
Age 46.1 (9.2) 54.8 (13.8) 52.8 (13.2) 0.2
Waist circumference (cm) 89.6 (5.7) 113 (6.5) 120.2 (11.5) ,0.001
Body mass index (kg/m2) 25.5 (2.10) 34.3 (5.02) 36.7 (6.3) ,0.001
Height (m) 1.76 (0.64) 1.78 (0.08) 1.74 (0.66) 0.351
Body weight (kg) 79.2 (7.6) 109 (13.8) 111 (18.5) ,0.001
Body weight/height ratio 0.51 (0.04) 0.64 (0.05) 0.69 (0.07) ,0.001
Percentage body fat 22.8 (6.8) 38.3 (6.1) 38.2 (7.0) ,0.001
Waist/hip ratio 0.88 (0.05) 0.96 (0.07) 1.05 (0.14) ,0.001
Plasma cholesterol (mmol/L) 4.73 (1.32) 5.24 (1.06) 4.38 (0.49) 0.17
Plasma HDL cholesterol (mmol/L) 1.28 (0.33) 1.15 (0.34) 1.19 (0.27) 0.54
Plasma LDL cholesterol (mmol/L) 3.08 (1.11) 3.38 (0.80) 2.54 (0.42) 0.082
Triglycerides (pmol/L) 1.09 (0.52) 1.42 (0.53) 1.80 (1.08) 0.04
OGTT plasma glucose 0 hours (mmol/L) 5.42 (0.74) 5.88 (0.68) 8.92 (2.82) ,0.001
OGTT plasma glucose 2 hours (mmol/L) 5.22 (2.13) 4.75 (1.3) 13.8 (3.80) ,0.001
Fasting plasma insulin (mU/I) 4.74 (2.77) 9.81 (4.03) 16.3 (10.6) ,0.001
Fasting plasma leptin (ng/mL) 4.08 (1.88) 15.60 (12.34) 19.44 (8.84) 0.006
C-reactive peptide (µg/mL) 1.22 (1.82) 2.39 (1.50) 2.78 (2.29) 0.127
HOMA-IR 1.19 (0.91) 2.66 (1.25) 6.39 (4.24) ,0.001
HOMA beta cell 52.6 (26.7) 80.9 (33.2) 84.6 (60.3) 0.032
QUICKI 1.12 (0.22) 1.44 (0.21) 1.66 (0.24) ,0.001
Notes: Data are mean (standard deviation) for all parameters. P values shown on the right are one-way analysis of variance.
Abbreviations: ANOVA, analysis of variance; BMI, body mass index; HDL, high-density lipoprotein; HOMA-IR, homeostatic model assessment of insulin resistance; LDL, 
low-density lipoprotein; OGTT, oral glucose tolerance testing; QUICKI, quantitative insulin-sensitivity check index.
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Target genes were then amplified by real-time polymerase 
chain reaction (PCR) using GoTaqTM qPCR Master Mix 
(Promega,   Southampton, UK) in a Roche LightCycler® 480 
System (Roche Diagnostics, Burgess Hill, UK).   Relative 
gene expression was calculated using the comparative 
Ct (2−∆∆Ct) method, as described previously.10
Statistical analyses
The statistical package GraphPad Prism 5 (GraphPad 
Software, La Jolla, CA) was used for analysis. Results are 
reported as mean ± standard deviation. One-way analysis 
of variance (ANOVA) was performed for analysis of more 
than two variables, followed by a post-hoc test for detection 
of significance. Simple linear correlation (Pearson’s correla-
tion) was used for quantitative data. Spearman correlation 
coefficient was used for qualitative data to estimate the asso-
ciation of RBP4 levels and BMI, leptin, insulin, adiponectin, 
CRP, cholesterol, triglycerides, HOMA-IR, waist/hip ratio, 
lean weight, fat mass, and percentage fat mass. The P value 
is significant if P # 0.05.
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Figure 1 Serum RBP4 protein levels in normal/overweight, obese, and obese/diabetic subjects treated with diet or metformin. (A) Serum RBP4 and TTR protein levels. One 
microliter of serum was denatured in SDS-loading buffer and subjected to SDS-PAGE analysis per individual. Quantification of serum (B) RBP4 and (C) TTR protein levels 
using Bio1D quantitative software. *Denotes P , 0.05; **P , 0.01.
Abbreviations: PAGE, polyacrylamide gel electrophoresis; RBP4, retinol-binding protein 4; SDS, sodium dodecyl sulfate; TTR, transthyretin.
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Figure 2 Adipose tissue RBP4 protein levels in normal/overweight, obese, and obese/diabetic subjects treated with diet or metformin. (A) Adipose tissue RBP4 and TTR 
protein levels. Ten micrograms of adipose tissue lysate was denatured in SDS-loading buffer and subjected to SDS-PAGE analysis per individual. Quantification of adipose 
tissue (B) RBP4 and (C) TTR protein levels using Bio1D quantitative software.
Abbreviations: PAGE, polyacrylamide gel electrophoresis; RBP4, retinol-binding protein 4; SDS, sodium dodecyl sulfate; TTR, transthyretin.
Results
There were no significant differences in age or height of the 
volunteers; however they had significantly different waist 
circumference (ANOVA; P , 0.001), BMI (P , 0.001), 
percentage body fat (P , 0.001), waist/hip ratio (P , 0.001), 
and leptin (P , 0.01) (Table 1). In addition, markers of 
insulin resistance between the three groups were signifi-
cantly different, namely OGTT at 0 and 2 hours (P , 0.001), 
fasting plasma glucose and insulin (P , 0.001), HOMA-IR 
(P , 0.001), and serum triglycerides (P , 0.05).
By using anti-human RBP4 and TTR antibodies, we 
found that obese subjects had significantly higher serum 
RBP4 protein levels in comparison to the normal/overweight 
subjects (ANOVA; P , 0.01; treatment effect P = 0.005, 
F = 6.046) (Figure 1A and B). Furthermore, in obese/ 
diabetic subjects treated with either diet or metformin, serum 
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RBP4 protein levels were completely normalized (ANOVA; 
P , 0.05)   (normal/overweight 1.34 × 106 ± 0.26 × 106 vs 
obese 1.64 × 106 ± 0.18 × 106 vs obese/diabetic 1.40 × 106 ± 
0.17 × 106), while serum TTR protein levels remained unal-
tered (Figure 1A and C).   Interestingly, while serum RBP4 
levels were upregulated in human obesity and normalized by 
improving whole body insulin sensitivity in obese subjects, 
the adipose tissue RBP4 protein levels were comparable 
between all three groups of subjects (Figure 2A and B) as 
were the serum and adipose tissue TTR levels (Figure 1A 
and C; Figure 2A and C).
To assess if serum and/or adipose RBP4 protein levels 
correlated with any of the adiposity or insulin sensitivity 
markers, we performed additional correlation analysis using 
the Spearman correlation coefficient (R) as done previously.5 
While BMI correlated significantly, as expected, with serum 
leptin (R = 0.89; P , 0.0001), insulin (R = 0.72; P , 0.0001), 
adiponectin (R = –0.48; P , 0.01), CRP (R = 0.46; P , 0.01), 
triglycerides (R = 0.36; P , 0.05), and HOMA-IR (R = 0.72; 
P , 0.0001), we found no correlation between serum and/or 
adipose RBP4 protein levels and any of the above-mentioned 
adiposity- and insulin-sensitivity markers (Table 2).
To assess if obesity led to an increase in ER stress-
response genes in the adipose tissue of our subjects and if 
this could be reversed by insulin sensitization, we analyzed 
adipose tissue gene expression of PTP1B, BIP, ATF4, and 
GRP94. In agreement with mouse studies, adipose tissue 
PTP1B gene expression levels were increased in obese 
subjects in comparison to the normal/overweight group 
(Figure 3A).1 However, this was not reversed with insulin 
sensitization in obese/diabetic subjects treated with diet or 
metformin, suggesting that in humans, as in mice, adipose 
tissue PTP1B does not regulate insulin sensitivity.1 Gene 
expression levels of other ER stress-response genes were not 
regulated by obesity or insulin sensitivity (Figure 3B–D).
Discussion
RBP4 is an adipokine proposed to be a marker of human 
insulin resistance, type 2 diabetes5 and gestational diabetes. 
RBP4 levels have been found to be normalized by certain 
antidiabetic drug treatments, such as rosiglitazone or 
pioglitazone,7 and lowering RBP4 levels has been suggested 
as a potential antidiabetic therapy. However, many studies 
have not been able to show this association between human 
obesity and insulin resistance and have found no correla-
tion between BMI and serum and/or adipose tissue mRNA 
RBP4 levels.22
In our volunteer study, we demonstrated that serum, but 
not adipose tissue, RBP4 protein levels are elevated in human 
obesity. We also showed that this can be completely reversed 
in obese/diabetic subjects treated with diet or metformin, in 
agreement with studies from other patient cohorts.5 Thus, 
improved insulin sensitivity in this small cohort study may be 
at least partly due to the lowering effects of diet or metformin 
on serum, but not adipose tissue, RBP4 levels. However, in 
agreement with other studies that found no correlation between 
the actual BMI22 and serum RBP4 levels, we also showed that 
serum and subcutaneous adipose tissue RBP4 protein levels 
Table 2 Correlations between plasma RBP4 and BMI, leptin, insulin, adiponectin, CRP, cholesterol, triglycerides, HOMA-IR, waist/hip 
ratio, lean weight, fat mass, and percentage fat mass
Clinical features Normal/overweight 
n = 12
Obese 
n = 9
Obese/diabetic 
n = 11
r P r P r P
Variables
BMI −0.01 0.487 −0.45 0.114 −0.17 0.307
Leptin −0.43 0.107 −0.2 0.307 0.23 0.251
Insulin −0.03 0.457 0.23 0.276 −0.31 0.177
Adiponectin −0.16 0.309 0.27 0.247 0.52 0.051*
CRP −0.315 0.159 −0.53 0.074 −0.12 0.364
Cholesterol 0.15 0.324 −0.07 0.44 0.43 0.09
Triglycerides 0.21 0.252 0.12 0.388 −0.06 0.426
HOMA-IR −0.06 0.431 0.37 0.168 −0.24 0.242
Waist/hip −0.08 0.406 0.30 0.218 0.03 0.462
Lean weight −0.17 0.301 −0.02 0.491 −0.47 0.071
Fat mass −0.07 0.414 0.07 0.44 0.07 0.416
% fat −0.01 0.483 −0.19 0.307 0.19 0.290
Note: P value is significant if P # 0.05.
Abbreviations: BMI, body mass index; CRP, C-reactive protein; HOMA-IR, homeostatic model assessment of insulin resistance; RBP4, retinol-binding protein 4.
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Figure 3 Adipose tissue relative mRNA levels of PTP1B, ATF4, GRP94, and BIP. 
Notes: Graphs A–D show relative mRNA levels of the indicated genes in adipose tissue, measured by quantitative real-time PCR and normalized against HPRT mRNA. 
n = 9 for the normal/overweight group; n = 7 for the obese group; and n = 8 for the obese/diabetic/treated group. Data are represented as mean ± SEM and analyzed using 
one-way ANOVA with post-hoc analysis. *Denotes P , 0.05.
Abbreviations: ANOVA, analysis of variance; ATF4, activated transcription factor 4; BIP, binding immunoglobulin protein; GRP94, glucose-regulated protein 94; HPRT, 
hypoxanthine-guanine phosphoribosyltransferase; PCR, polymerase chain reaction; PTP1B, protein tyrosine phosphatase 1B; SEM, standard error of mean.
do not correlate with BMI nor do they correlate with any other 
known investigated adiposity- and insulin-sensitivity markers. 
This suggests that there may be other factors responsible for the 
observed rise in serum RBP4 protein levels during the progres-
sion of human obesity. Some studies, however, have found an 
association between serum RBP4 levels and visceral fat,23,24 
and it is possible that serum RBP4 levels would correlate 
directly with this. Since we did not have accurate data on 
visceral fat for each volunteer, which is normally obtained by 
magnetic resonance imaging, we cannot exclude the possibility 
that these would show a correlation.
We also demonstrate that in human subcutaneous adipose 
tissue, PTP1B expression levels are regulated by obesity 
in agreement with the mouse studies that demonstrate that 
adipose tissue PTP1B levels are upregulated upon high-fat 
diet feeding.1 In agreement with the mouse studies, fur-
thermore, we also observe that an increase in adipose tis-
sue PTP1B levels in human obesity cannot be reversed by 
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improvements in insulin sensitivity in obese/diabetic subjects 
treated with diet or metformin.
On the other hand, the levels of the other ER stress-
response genes remain unaltered in the adipose tissue of the 
three study groups, suggesting that perhaps the ER stress-
response pathway may not play a major role in this tissue in 
human obesity. We should, however, be cautious at interpret-
ing these data due to the relatively low sample size that we 
had available for this specific study; perhaps a larger study 
size is required to quantitatively examine the role of the ER 
stress-response pathway in human obesity.
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